Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Gossamer Bio Q2 2024 GAAP EPS $0.22 Beats $0.16 Estimate, Sales $95.842M Miss $114.286M Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:04pm
Gossamer Bio (NASDAQ:GOSS) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.16 by 37.5 percent. The company reported quarterly sales of $95.842 million which missed the analyst consensus estimate of $114.286 million by 16.14 percent.

Posted In: GOSS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist